Moderna files for US vaccine authorization, will seek EU nod

A shot developed by Pfizer Inc and BioNTech SE that was 95% effective in its pivotal trial is set to be reviewed by a panel of outside experts a week earlier. The FDA will decide on the emergency use authorizations (EUA)after the advisers make their recommendations.

from Hindustan Times - world https://bit.ly/3fUxInm
https://ift.tt/2zbki14